UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (12657) 12657
Book Chapter (255) 255
Newspaper Article (76) 76
Magazine Article (31) 31
Newsletter (22) 22
Book / eBook (20) 20
Dissertation (9) 9
Conference Proceeding (1) 1
Publication (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (11636) 11636
female (11598) 11598
science & technology (9656) 9656
life sciences & biomedicine (9426) 9426
middle aged (6210) 6210
endometrial cancer (6077) 6077
oncology (5668) 5668
endometrial neoplasms - pathology (5250) 5250
aged (4872) 4872
adult (4144) 4144
obstetrics & gynecology (3800) 3800
cancer (3598) 3598
neoplasm staging (2420) 2420
aged, 80 and over (2155) 2155
endometrial neoplasms - surgery (2153) 2153
prognosis (2086) 2086
risk factors (1911) 1911
endometrial neoplasms - drug therapy (1848) 1848
retrospective studies (1819) 1819
endometrial neoplasms - genetics (1459) 1459
endometrial neoplasms - metabolism (1393) 1393
endometrial neoplasms - therapy (1385) 1385
obstetrics and gynecology (1264) 1264
hysterectomy (1252) 1252
research (1243) 1243
endometrial neoplasms - mortality (1234) 1234
endometrium (1227) 1227
care and treatment (1210) 1210
treatment outcome (1196) 1196
endometrial neoplasms - radiotherapy (1186) 1186
endometrial carcinoma (1184) 1184
health aspects (1164) 1164
endometrial neoplasms - diagnosis (1136) 1136
analysis (1117) 1117
hematology, oncology and palliative medicine (1112) 1112
abridged index medicus (1002) 1002
surgery (1000) 1000
endometrial neoplasms - epidemiology (971) 971
follow-up studies (968) 968
ovarian cancer (955) 955
immunohistochemistry (938) 938
pathology (921) 921
survival rate (921) 921
chemotherapy (898) 898
adenocarcinoma - pathology (869) 869
tumors (866) 866
endometrium - pathology (865) 865
cell line, tumor (802) 802
breast cancer (798) 798
metastasis (766) 766
combined modality therapy (759) 759
medicine & public health (731) 731
animals (729) 729
carcinoma, endometrioid - pathology (721) 721
endometrial neoplasms - chemically induced (690) 690
disease-free survival (676) 676
lymphatic metastasis (650) 650
neoplasm invasiveness (650) 650
gynecology (643) 643
oncology, experimental (643) 643
breast neoplasms - drug therapy (636) 636
radiology, nuclear medicine & medical imaging (632) 632
radiotherapy (626) 626
prospective studies (625) 625
endometrial neoplasms (615) 615
carcinoma (597) 597
postmenopause (596) 596
women (593) 593
survival analysis (584) 584
chemotherapy, adjuvant (570) 570
diagnosis (568) 568
case-control studies (559) 559
radiotherapy, adjuvant (554) 554
antineoplastic combined chemotherapy protocols - therapeutic use (535) 535
endometrial neoplasms - etiology (531) 531
tamoxifen - adverse effects (531) 531
lymph node excision (529) 529
genetic aspects (527) 527
menopause (523) 523
cervical cancer (521) 521
uterine neoplasms - pathology (516) 516
mutation (515) 515
hormone replacement therapy (513) 513
gene expression (506) 506
ovarian neoplasms - pathology (491) 491
estrogen (485) 485
male (483) 483
neoplasm recurrence, local - pathology (479) 479
time factors (476) 476
cohort studies (475) 475
development and progression (474) 474
patients (472) 472
biopsy (466) 466
survival (466) 466
gene expression regulation, neoplastic (459) 459
antineoplastic agents, hormonal - therapeutic use (454) 454
neoplasm grading (450) 450
medical prognosis (437) 437
tamoxifen - therapeutic use (437) 437
tamoxifen (433) 433
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (12452) 12452
French (184) 184
German (157) 157
Japanese (109) 109
Chinese (104) 104
Russian (86) 86
Polish (57) 57
Spanish (45) 45
Italian (41) 41
Korean (29) 29
Bulgarian (26) 26
Portuguese (22) 22
Czech (17) 17
Hungarian (17) 17
Norwegian (8) 8
Danish (7) 7
Dutch (7) 7
Hebrew (7) 7
Swedish (6) 6
Romanian (4) 4
Serbian (4) 4
Finnish (2) 2
Arabic (1) 1
Bosnian (1) 1
Croatian (1) 1
Persian (1) 1
Slovak (1) 1
Slovenian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Current drug targets, ISSN 1389-4501, 11/2015, Volume 16, Issue 12, pp. 1381 - 1403
MicroRNAs (miRNAs) are small single stranded non coding RNA molecules (similar to 22 nucleotides) which impede protein production by directly interacting with... 
Epithelial to mesenchymal transition | Biomarker | Tumor microenvironment | Tumor suppressor | MicroRNAs | MiR-200c | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | MicroRNAs - therapeutic use | Neoplasms - metabolism | Lung Neoplasms - drug therapy | Prostatic Neoplasms - metabolism | Pancreatic Neoplasms - metabolism | Pancreatic Neoplasms - diagnosis | Humans | Lung Neoplasms - metabolism | Endometrial Neoplasms - metabolism | Stomach Neoplasms - metabolism | Male | MicroRNAs - metabolism | Antineoplastic Agents - therapeutic use | Neoplasms - diagnosis | Prostatic Neoplasms - diagnosis | Colorectal Neoplasms - diagnosis | Breast Neoplasms - metabolism | Pancreatic Neoplasms - drug therapy | Biomarkers, Tumor - therapeutic use | Colorectal Neoplasms - drug therapy | Biomarkers, Tumor - metabolism | Female | Ovarian Neoplasms - metabolism | Ovarian Neoplasms - drug therapy | Colorectal Neoplasms - metabolism | Prostatic Neoplasms - drug therapy | Stomach Neoplasms - diagnosis | Ovarian Neoplasms - diagnosis | Biomarkers, Tumor - physiology | Stomach Neoplasms - drug therapy | Endometrial Neoplasms - diagnosis | Breast Neoplasms - drug therapy | Neoplasms - drug therapy | Animals | Endometrial Neoplasms - drug therapy | Breast Neoplasms - diagnosis | MicroRNAs - physiology | Lung Neoplasms - diagnosis
Journal Article
PloS one, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, pp. e0145754 - e0145754
... clinical response to their primary therapy, nearly half will develop disease recurrence within 18 months and the majority will die from disease recurrence within 5 years... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Endometrial Neoplasms - mortality | Humans | Middle Aged | Ovarian Neoplasms - mortality | Genital Neoplasms, Female - drug therapy | DNA, Neoplasm - blood | Endometrial Neoplasms - genetics | Adult | Female | Neoplasm Recurrence, Local - blood | Ovarian Neoplasms - drug therapy | Genital Neoplasms, Female - genetics | CA-125 Antigen - blood | Ovarian Neoplasms - blood | Genital Neoplasms, Female - blood | Mutation - genetics | Breast Neoplasms - drug therapy | Biomarkers, Tumor - blood | Genital Neoplasms, Female - mortality | Exome - genetics | Breast Neoplasms - genetics | Breast Neoplasms - blood | Breast Neoplasms - mortality | Endometrial Neoplasms - drug therapy | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | Endometrial Neoplasms - blood | Physiological aspects | Prognosis | Biological markers | Genital cancer | Tumors | Plasma | Scanning | Ovarian carcinoma | Fallopian tube | Cancer therapies | Ovarian cancer | Gene sequencing | Computed tomography | Surgery | Quality | Imaging | Endometrium | Deoxyribonucleic acid--DNA | DNA probes | Gynecology | Breast cancer | Patients | Survival | Obstetrics | Medicine | Lead time | Chemotherapy | Surveillance | Womens health | Biomarkers | Diagnostic systems | Mutation | Reproductive system | Uterine cancer | Peritoneum | Cancer | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article
Cancer chemotherapy and pharmacology, ISSN 1432-0843, 07/2019, Volume 84, Issue 3, pp. 487 - 499
Enzymes of the cytochrome P450 (CYP) subfamily 3A and 2C play a major role in the metabolism of taxane anticancer agents. While their function in hepatic... 
Intratumoral | Ritonavir | Paclitaxel | Docetaxel | CYP | Review | Journal Article | Medicine & Public Health | Oncology | Cancer Research | Pharmacology/Toxicology | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Taxoids - pharmacology | Humans | Ovarian Neoplasms - pathology | Drug Resistance, Neoplasm | Lung Neoplasms - pathology | Male | Breast Neoplasms - enzymology | Female | Antineoplastic Agents - pharmacology | Cytochrome P-450 CYP2C8 - metabolism | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Endometrial Neoplasms - enzymology | Lung Neoplasms - enzymology | Neoplasms - enzymology | Breast Neoplasms - drug therapy | Ovarian Neoplasms - enzymology | Neoplasms - drug therapy | Breast Neoplasms - pathology | Cytochrome P-450 CYP3A - metabolism | Prostatic Neoplasms - enzymology | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Neoplasms - pathology | Antimitotic agents | Protease inhibitors | Proteases | Pharmacy | Cytochrome P-450 | Physiological aspects | Drugstores | Antineoplastic agents | Ovarian cancer | Cytochrome | Enzymes | Cytochrome P450 | Proteinase inhibitors | Taxane | Metabolism | Anticancer properties | Antitumor agents | Lungs | Drug metabolism | Breast | Solid tumors | Taxanes | Prostate | Endometrium | Tumors | Cytochromes P450 | Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 12/2015, Volume 33, Issue 34, pp. 4015 - 4022
Journal Article
Cancer, ISSN 0008-543X, 08/2017, Volume 123, Issue 16, pp. 3080 - 3087
...INTRODUCTION The use of chemotherapeutic drugs has long provided a foundation for systemic cancer therapy; however, their effectiveness is commonly hampered... 
clinical trial | targeted therapy | folate receptor | phase 1 | antibody‐drug conjugate | antibody-drug conjugate | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - drug therapy | Humans | Middle Aged | Ovarian Neoplasms - pathology | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Fatigue - chemically induced | Diarrhea - chemically induced | Dose-Response Relationship, Drug | Vision Disorders - chemically induced | Aged, 80 and over | Immunoconjugates - therapeutic use | Adult | Female | Hypophosphatemia - chemically induced | Carcinoma, Renal Cell - drug therapy | Ovarian Neoplasms - drug therapy | Carcinoma, Non-Small-Cell Lung - pathology | Neoplasms, Glandular and Epithelial - pathology | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Renal Cell - pathology | Maytansine - analogs & derivatives | Keratitis - chemically induced | Maytansine - therapeutic use | Disease Progression | Neoplasms - drug therapy | Maximum Tolerated Dose | Neoplasms, Glandular and Epithelial - drug therapy | Carcinoma, Ovarian Epithelial | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Kidney Neoplasms - pathology | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Kidney Neoplasms - drug therapy | Neoplasms - pathology | Cancer patients | Care and treatment | Pharmacokinetics | Health aspects | Analysis | Ovarian cancer | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 04/2013, Volume 31, Issue 12, pp. 1554 - 1561
Journal Article